InsidersTradesSigma
멕아이씨에스 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 멕아이씨에스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 멕아이씨에스 has recorded 10 insider filings. Market capitalisation: €29.3bn. The latest transaction was disclosed on 16 June 2026 (Other). Among the most active insiders: 오정택. Every trade is openly available.
10
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
0 ops.
Sell Volume
8Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,655 of 26,282 companies
28.9
score / 100
Value17
Quality41
FCF yld-8.6%
Earn yld-8.6%
EV/EBITDA·
ROE·
Gross mgn55%
Net mgn-22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 June 2026
Declarations10 total
10 of 10 declarations
About 멕아이씨에스
멕아이씨에스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It specializes in developing innovative solutions for the medical field.